Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth P Gregory

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|January 22, 2024
New standards of care for treatment of diffuse large B-cell lymphomaChathuri Abeyakoon, Gareth P Gregory
Journal of Personalized Medicine|May 5, 2021
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell LymphomasRoss Salvaris, Jeremy Ong, Gareth P Gregory
Annals of Hematology|January 5, 2017
Cold agglutinin disease complicated by acrocyanosis and necrosisGareth P Gregory, Ann Farrell, Susan Brown
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' replyJeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Leukemia & Lymphoma|June 21, 2021
Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISHJasmine Singh, Adam Facey, Fran O'Malley, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|January 22, 2024
New standards of care for treatment of diffuse large B-cell lymphomaChathuri Abeyakoon, Gareth P Gregory
Journal of Personalized Medicine|May 5, 2021
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell LymphomasRoss Salvaris, Jeremy Ong, Gareth P Gregory
Annals of Hematology|January 5, 2017
Cold agglutinin disease complicated by acrocyanosis and necrosisGareth P Gregory, Ann Farrell, Susan Brown
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' replyJeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Leukemia & Lymphoma|June 21, 2021
Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISHJasmine Singh, Adam Facey, Fran O'Malley, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 5